Boji Medical Technology Co.,Ltd.

SZSE:300404 Stock Report

Market Cap: CN¥3.4b

Boji Medical TechnologyLtd Management

Management criteria checks 4/4

Boji Medical TechnologyLtd's CEO is Tingchun Wang, appointed in Jun 2011, has a tenure of 13.5 years. directly owns 33.25% of the company’s shares, worth CN¥1.15B. The average tenure of the management team and the board of directors is 9.6 years and 4.4 years respectively.

Key information

Tingchun Wang

Chief executive officer

CN¥414.0k

Total compensation

CEO salary percentagen/a
CEO tenure13.5yrs
CEO ownership33.3%
Management average tenure9.6yrs
Board average tenure4.4yrs

Recent management updates

Recent updates

We Don’t Think Boji Medical TechnologyLtd's (SZSE:300404) Earnings Should Make Shareholders Too Comfortable

Nov 02
We Don’t Think Boji Medical TechnologyLtd's (SZSE:300404) Earnings Should Make Shareholders Too Comfortable

A Piece Of The Puzzle Missing From Boji Medical Technology Co.,Ltd.'s (SZSE:300404) 39% Share Price Climb

Oct 08
A Piece Of The Puzzle Missing From Boji Medical Technology Co.,Ltd.'s (SZSE:300404) 39% Share Price Climb

Boji Medical TechnologyLtd's (SZSE:300404) Profits Appear To Have Quality Issues

May 01
Boji Medical TechnologyLtd's (SZSE:300404) Profits Appear To Have Quality Issues

Further Upside For Boji Medical Technology Co.,Ltd. (SZSE:300404) Shares Could Introduce Price Risks After 35% Bounce

Mar 06
Further Upside For Boji Medical Technology Co.,Ltd. (SZSE:300404) Shares Could Introduce Price Risks After 35% Bounce

CEO

Tingchun Wang (59 yo)

13.5yrs

Tenure

CN¥414,000

Compensation

Mr. Tingchun Wang, M.D. & Ph D., is a Founder of Boji Medical Technology Co.,Ltd. and has been its General Manager and Chairman since June 11, 2011.Mr. Wang serves as Member of the Board at Guangzhou Funw...


Leadership Team

NamePositionTenureCompensationOwnership
Tingchun Wang
Founder13.5yrsCN¥414.00k33.25%
CN¥ 1.1b
Xiu Qing Ou
Deputy GM & CFO13.5yrsCN¥461.80k0.099%
CN¥ 3.4m
Quan Zhu
Deputy GM & Director9.6yrsCN¥1.44m0.077%
CN¥ 2.6m
Bo Tan
Deputy GM & Director9.6yrsCN¥937.60k0.072%
CN¥ 2.5m
Yu Ping Han
Deputy General Managerno dataCN¥865.90k0.072%
CN¥ 2.5m
Shaobo Wen
Deputy General Manager3.7yrsCN¥1.27m0.019%
CN¥ 643.2k
Lian Zuo
Deputy General Manager3yrsCN¥1.20m0.011%
CN¥ 381.3k
Zhanpeng Chen
Accounting Supervisorno datano datano data

9.6yrs

Average Tenure

51yo

Average Age

Experienced Management: 300404's management team is seasoned and experienced (9.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Tingchun Wang
Founder13.5yrsCN¥414.00k33.25%
CN¥ 1.1b
Quan Zhu
Deputy GM & Director9.6yrsCN¥1.44m0.077%
CN¥ 2.6m
Bo Tan
Deputy GM & Director9.6yrsCN¥937.60k0.072%
CN¥ 2.5m
Kejian Zhang
Director4.4yrsCN¥84.00kno data
Qing Chen
Independent Director4.4yrsCN¥84.00kno data
Wang Fang
Supervisor4.4yrsno datano data
Kang Xie
Independent Director2.6yrsCN¥84.00kno data
Huayi Li
Independent Director1.3yrsCN¥35.00kno data
Peidan Xian
Non-Employee Supervisor1.3yrsno datano data

4.4yrs

Average Tenure

52yo

Average Age

Experienced Board: 300404's board of directors are considered experienced (4.4 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 23:26
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Boji Medical Technology Co.,Ltd. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Siao YeEverbright Securities Co. Ltd.
Kehan MengHaitong International Research Limited